Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study
Song Yao, Qiang Hu, Sarah L. Kerns, et al.
Clinical Epigenetics (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Origins of human disease: the chrono-epigenetic perspective
Edward Oh, Artūras Petronis
Nature Reviews Genetics (2021) Vol. 22, Iss. 8, pp. 533-546
Closed Access | Times Cited: 83
A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment
Ambrose Okem, Charlotte Henstra, Maarten Lambert, et al.
Medicine in Drug Discovery (2022) Vol. 17, pp. 100147-100147
Open Access | Times Cited: 34
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities
Allison Magnuson, Tim A. Ahles, Bihong T. Chen, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 19, pp. 2138-2149
Open Access | Times Cited: 40
Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers
Jeanne S. Mandelblatt, Tim A. Ahles, Marc E. Lippman, et al.
JAMA Oncology (2021) Vol. 7, Iss. 11, pp. 1692-1692
Open Access | Times Cited: 36
DNA methylation changes following narrative exposure therapy in a randomized controlled trial with female former child soldiers
Samuel Carleial, Daniel Nätt, Eva Unternährer, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
Jinguo Zhang, Shuaikang Pan, Jian Chen, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 22
Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis
Hua Guo, Jinyang Gao, Liping Gong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Dynamic predictive power of TP53 signatures in breast cancer prognosis: Pre- and post-neoadjuvant chemotherapy insights
Keiju Sasaki, Shin Takahashi, Kota Ouchi, et al.
Translational Oncology (2025) Vol. 56, pp. 102398-102398
Closed Access
Association between Serum Vitamin B12 and Global DNA Methylation in Colorectal Cancer Patients
Hatim Boughanem, Pablo Hernández‐Alonso, Alberto Tinahones, et al.
Nutrients (2020) Vol. 12, Iss. 11, pp. 3567-3567
Open Access | Times Cited: 32
Comprehensive RNA Sequencing in Adenoma-Cancer Transition Identified Predictive Biomarkers and Therapeutic Targets of Human CRC
Mingzhe Zhu, Yanqi Dang, Zhenhua Yang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 25-33
Open Access | Times Cited: 31
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer
Romina Silva, Bruce Moran, Anne‐Marie Baird, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Persistent variations of blood DNA methylation associated with treatment exposures and risk for cardiometabolic outcomes in long-term survivors of childhood cancer in the St. Jude Lifetime Cohort
Nan Song, Chia‐Wei Hsu, Haitao Pan, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Circular RNA circBFAR promotes glioblastoma progression by regulating a miR‐548b/FoxM1 axis
Chenlong Li, Xue Guan, Hanguang Jing, et al.
The FASEB Journal (2022) Vol. 36, Iss. 3
Open Access | Times Cited: 18
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Methods in DNA methylation array dataset analysis: A review
Karishma Sahoo, Vino Sundararajan
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2304-2325
Open Access | Times Cited: 3
The acceleration of ageing in older patients with cancer
Jaidyn Muhandiramge, Suzanne G. Orchard, Andrew Haydon, et al.
Journal of Geriatric Oncology (2020) Vol. 12, Iss. 3, pp. 343-351
Closed Access | Times Cited: 22
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
Gang Xu, Xiaoxiang Zhou, Jiali Xing, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Changes in methylation-based aging in women who do and do not develop breast cancer
Jacob K. Kresovich, Katie M. O’Brien, Zongli Xu, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1329-1336
Open Access | Times Cited: 7
A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes
Mostafa Mohamed, Mustafa M. Ahmed, AnnaLynn M. Williams, et al.
Journal of Cancer Survivorship (2024) Vol. 18, Iss. 4, pp. 1089-1130
Open Access | Times Cited: 2
The National Cancer Institute Clinical Trials Planning Meeting to Address Gaps in Observational and Intervention Trials for Cancer-Related Cognitive Impairment
Michelle C. Janelsins, Kathleen Van Dyk, Sheri J. Hartman, et al.
JNCI Journal of the National Cancer Institute (2024)
Open Access | Times Cited: 2
Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy
Zhaoming Wang, Jinghui Zhang
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 2
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome
Vallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 5, pp. 738-754
Open Access | Times Cited: 6
An update in toxicology of ageing
Lucia Račková, Mojmı́r Mach, Zuzana Brnoliaková
Environmental Toxicology and Pharmacology (2021) Vol. 84, pp. 103611-103611
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top